REPLIGEN CORP
REPLIGEN CORP
Action · US7599161095 · RGEN · 870980 (XNAS)
Aperçu
Résumé de la Note des Analystes
gauge-img
Achat
Achat fort
Achat
Conserver
Vente
Vente forte
1
19
3
0
0
Pas de cours
27.10.2025 18:58
Cours actuels de REPLIGEN CORP
BourseTickerDeviseDernier échangeCoursVariation journalière
XNAS: NASDAQ
NASDAQ
RGEN
USD
27.10.2025 18:58
162,69 USD
-3,64 USD
-2,19 %
Flottant et Liquidité des Actions
Flottant Libre 93,60 %
Actions en Flottant 52,66 M
Actions en Circulation 56,26 M
Profil de l'entreprise pour REPLIGEN CORP Action
Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products. The company's chromatography products include OPUS pre-packed chromatography columns, which are used in the purification of biologics; and OPUS smaller-scale columns that are used in the high throughput process development screening, viral clearance validation studies, and scale down validation of chromatography processes. It also offers ELISA test kits; and chromatography resins under the CaptivA brand. In addition, the company provides filtration products, such as XCell Alternating Tangential Flow systems that are filtration devices used in upstream perfusion and cell culture processing; TangenX flat sheet cassettes, which are used in downstream biologic drug concentration and formulation processes; KrosFlo tangential flow filtration and tangential flow depth filtration systems; Spectra/Por laboratory and process dialysis products, and SpectraFlo dynamic dialysis systems; and ProConnex single-use hollow fiber. Further, it provides process analytics products, such as slope spectroscopy systems under the SoloVPE, FlowVPE, and FlowVPX brands. The company sells its products to life sciences, biopharmaceutical, and diagnostics companies; laboratory researchers; and contract manufacturing organizations. Repligen Corporation has collaboration agreements with Navigo Proteins GmbH to develop multiple affinity ligands. Repligen Corporation was incorporated in 1981 and is headquartered in Waltham, Massachusetts.
Obtenez des informations actualisées de finAgent sur REPLIGEN CORP

Données de l'entreprise

Nom REPLIGEN CORP
Société Repligen Corporation
Symbole RGEN
Site web https://www.repligen.com
Marché d'origine XNAS NASDAQ
WKN 870980
ISIN US7599161095
Type de titre Action
Secteur Healthcare
Industrie Medical - Instruments & Supplies
PDG Olivier Loeillot
Capitalisation boursière 7 Mrd.
Pays États-Unis d'Amérique
Devise USD
Employés 1,8 T
Adresse Building 1, 02453 Waltham
Date d'introduction en bourse 1986-04-29

Symboles boursiers

Nom Symbole
Frankfurt RGN.F
NASDAQ RGEN
Autres actions
Les investisseurs qui détiennent REPLIGEN CORP ont également les actions suivantes dans leur portefeuille :
ADOBE INC
ADOBE INC Action
AMAZON.CO INC
AMAZON.CO INC Action
AMERICAN FINANCIAL GROUP INC5.125% SUBORDINATED DEBENTURES DUE 2059
AMERICAN FINANCIAL GROUP INC5.125% SUBORDINATED DEBENTURES DUE 2059 Action
AMGEN INC
AMGEN INC Action
AUTODESK INC
AUTODESK INC Action
CISCO SYSTEMS INC
CISCO SYSTEMS INC Action
COSTCO WHOLESALE CORP
COSTCO WHOLESALE CORP Action
EARTH GOLD FUND UI EUR R
EARTH GOLD FUND UI EUR R Fonds
MICROCHIP TECHNOLOGIESLOGY INC
MICROCHIP TECHNOLOGIESLOGY INC Action
MICROSOFT CORP
MICROSOFT CORP Action
NETFLIX INC
NETFLIX INC Action
O'REILLY AUTOMOTIVE INC
O'REILLY AUTOMOTIVE INC Action
OWENS-BROCKWAY 15/23 REGS
OWENS-BROCKWAY 15/23 REGS Obligation
RED PULSE PHX
RED PULSE PHX Crypto
La plateforme financière MoneyPeak suit et analyse les investissements et les portefeuilles. Du dépôt de titres à l'achat de crypto.
Utile, simple et gratuit. Actions, ETF, ETC, ETN, indices, fonds, obligations, certificats, devises, options, droits de souscription.
Mentions légales Protection des données Blog Communauté Retour d'information Changelog
Im App Store herunterladen Bei Google Play herunterladen
Tous droits réservés © LCP GmbH 2025